Copyright
©The Author(s) 2021.
World J Hepatol. Jul 27, 2021; 13(7): 804-814
Published online Jul 27, 2021. doi: 10.4254/wjh.v13.i7.804
Published online Jul 27, 2021. doi: 10.4254/wjh.v13.i7.804
Table 3 Reported data concerning the safety of thromboprophylaxis for venous thromboembolism during liver resection
Ref. | Year, type | Surgery type | Drug use and exposure | Bleeding events | TE, mortality |
Ainoa et al[15] | 2020, RCS | Liver resection (n = 512) | Patients with preop TP (n = 253); Patients with postop TP (control, n = 259) | BC 15.0% in preop TP vs 13.9% in control (P > 0.05) | VTE 1.2% vs 9.7% (P < 0.0001); PE 1.2% vs 9.3% (P < 0.0001) |
Ejaz et al[16] | 2014, RCS | Liver resection (n = 599) | Patients with TP (n = 454); Patients without TP (control, n = 145) | Not mentioned | VTE 5.1% in TP vs 3.4% in control (P = 0.42) |
Nathan et al[17] | 2014, RCS | Liver resection (n = 2147) | Patients with early TP (n = 1295); Patients with late or no TP (control, n = 852) | Major BC 1.7% in early TP vs 1.6% in control (P > 0.05) | VTE 2.1% vs 3.3% (P > 0.05); Overall mortality 1.9% |
Eguchi et al[18] | 2020, mPCS | Major HBP surgery (n = 133) including 74 liver resection | Patients with TP [LMWH (enoxaparin), n = 133, single arm] | Major BC 2.3%; Minor BC 5.2% | No PE event in whole cohort |
Hayashi et al[19] | 2014, RCS | Major HBP surgery (n = 349) including 138 liver resection | Patients with TP (n = 207); Patients without TP (control, n = 142) | BC 26.6% in TP vs 8.5% in control (P < 0.05); Rate of major BC is identical | VTE 2.9% vs 7.7% (P > 0.05) |
Wang et al[20] | 2018, CCS | Liver resection (n = 233) | Patients with TP (LMWH, n = 117); Patients without TP (control, n = 116) | Not mentioned | VTE 0.85% in TP vs 13.8% (P < 0.05) |
Kim et al[21] | 2017, RCS | Liver resection (n = 124) | Patients with extended TP [LMWH (enoxaparin), n = 124, single arm] | BC 1.6% in extended TP | No VTE in whole cohort |
Doughtie et al[22] | 2014, RCS | Major HBP surgery (n = 223) including 110 liver resection | Patients with preop TP (LMWH, n = 93); Patients without preop TP (control, n = 130) | Major BC 10.9% in preop TP vs 3.1% in control (P = 0.026); SBL was identical | VTE 1.1% vs 6.1% (P = 0.05) |
Melloul et al[23] | 2012, RCS | Liver resection (n = 410) | Patients with TP (n = 410, single arm) | Not mentioned | PE 6% (24/410) in TP |
Reddy et al[24] | 2011, RCS | Major liver resection (n = 419) | Patients with TP (n = 275); Patients without TP (control, n = 144) | RBC transfusion rate 35.0% in TP vs 30.6% in control (P = 0.36) | CR-VTE 2.2% in TP vs 6.3% in control (P = 0.03); PE 2.2% vs 4.2% (P = 0.35) |
- Citation: Fujikawa T. Safety of liver resection in patients receiving antithrombotic therapy: A systematic review of the literature. World J Hepatol 2021; 13(7): 804-814
- URL: https://www.wjgnet.com/1948-5182/full/v13/i7/804.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i7.804